7-37907573-G-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The ENST00000436072.7(SFRP4):c.947C>A(p.Pro316Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00129 in 1,613,730 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000436072.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFRP4 | NM_003014.4 | c.947C>A | p.Pro316Gln | missense_variant | 6/6 | ENST00000436072.7 | NP_003005.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFRP4 | ENST00000436072.7 | c.947C>A | p.Pro316Gln | missense_variant | 6/6 | 1 | NM_003014.4 | ENSP00000410715 | P1 | |
SFRP4 | ENST00000478975.1 | n.315C>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000763 AC: 116AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000581 AC: 146AN: 251350Hom.: 0 AF XY: 0.000530 AC XY: 72AN XY: 135854
GnomAD4 exome AF: 0.00135 AC: 1969AN: 1461508Hom.: 5 Cov.: 32 AF XY: 0.00127 AC XY: 921AN XY: 727074
GnomAD4 genome AF: 0.000762 AC: 116AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.000726 AC XY: 54AN XY: 74430
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2022 | This sequence change replaces proline, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 316 of the SFRP4 protein (p.Pro316Gln). This variant is present in population databases (rs147145122, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SFRP4-related conditions. ClinVar contains an entry for this variant (Variation ID: 1377522). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.947C>A (p.P316Q) alteration is located in exon 6 (coding exon 6) of the SFRP4 gene. This alteration results from a C to A substitution at nucleotide position 947, causing the proline (P) at amino acid position 316 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at